| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Director
2 companies
Steinhart Richard I is a Chief Financial Officer at BioXcel Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 0 sells.
Estimated insider holdings value: $32K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2018 | BTAI Bioxcel Therapeutics, Inc. | Chief Financial Officer | Buy | 500 | $5.00 | $2,500.00 | New | |
| Apr 14, 2016 | ATNM Actinium Pharmaceuticals, Inc. | Director | Buy | 2,500 | $2.01 | $5,025.00 | New |